Loading...
Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
Cisplatin represents one of the first‐line drugs used for non‐small‐cell lung cancer treatment. However, considerable side effects and the emergence of drug resistance are becoming critical limitations to its application. Combinatorial strategies may be able to extend the use of cisplatin. Both Tans...
Na minha lista:
| Udgivet i: | Phytother Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6772065/ https://ncbi.nlm.nih.gov/pubmed/31268205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ptr.6392 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|